The University of Oklahoma — Oklahoma City, Oklahoma

The University of Oklahoma is a clinical research site located in Oklahoma City, Oklahoma, United States 73117.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

The University of Oklahoma has participated in 5 clinical trials with 1 currently active.

Therapeutic areas: Recurrent Malignant Glioma, Brain Glioblastoma, Metabolic Disorders.

Sponsors: Oblato, Inc., Washington University School of Medicine, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Oklahoma?

The University of Oklahoma has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Oklahoma conducted?

The University of Oklahoma has 5 clinical trials on record, with 1 currently active. Their work covers Recurrent Malignant Glioma, Brain Glioblastoma, Metabolic Disorders.

Is The University of Oklahoma accredited by Crixeo Health?

Yes — The University of Oklahoma holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about The University of Oklahoma?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.